DEA Increases Production Quota for Vyvanse (lisdexamfetamine) The Drug Enforcement Administration (DEA) has recently authorized an increase in the production quota for lisdexamfetamine, a crucial medication used to treat Attention Deficit Hyperactivity Disorder (ADHD), by approximately 23.5%
Ever feel like your brains stuck in a fog or your energy levels are flagging, no matter how much coffee youve had
The mechanistic rationale is dual-receptor stimulation: GHRH receptor activation by the GHRH analogue plus ghrelin-receptor activation by the GHRP
While Semaglutide is highly effective for weight loss and managing type 2 diabetes, it may cause some mild to moderate side effects, such as nausea, diarrhea, or stomach discomfort, particularly during the initial weeks of treatment
Comparison of individual and standard kinetic parameters for C-peptide clearance
The food intake suppressive effects of chronic amylin and GLP-1R analog treatments were evaluated in rats with ad libitum free-choice of chow and HFSD and are expressed in Kcal from food ( n = 1011 per diet/drug/group) over the 32 days of treatment following 5 weeks of ad libitum diet maintenance